TNGX NASDAQ
Tango Therapeutics, Inc.
1W: -13.1%
1M: -19.8%
3M: +77.2%
YTD: +142.1%
1Y: +944.4%
3Y: +502.2%
5Y: +88.3%
$20.24
-1.38 (-6.38%)
Weekly Expected Move ±13.8%
$15
$18
$21
$23
$26
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.00
Neutral
2 bullish
2 neutral
2 bearish
Articles (7d)
6
Daily Sentiment (7 Days)
Articles (100)
Tango Therapeutics: 'Hold' On Combination Strategy Shift Of Vopimetostat (NASDAQ:TNGX) - Seeking Alpha
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy
Tango Therapeutics (TNGX) Is Down 10.7% After Pipeline Pivot And Board Changes - Has The Bull Case Changed?
Tango Therapeutics (TNGX) Is Down 10.7% After Pipeline Pivot And Board Changes - Has The Bull Case Changed? - Yahoo Finance
Assessing Tango Therapeutics (TNGX) Valuation After Trial Progress And Leadership Changes - simplywall.st
TNGX stock crashes 20% after reporting $0 revenue in Q1 — but analysts still see massive upside - MSN
TNGX stock crashes 20% after reporting $0 revenue in Q1 — but analysts still see massive upside - MSN
[SCHEDULE 13G/A] Tango Therapeutics, Inc. Amended Passive Investment Disclosure - Stock Titan
Nextech Crossover reports 7.27M-share stake in Tango Therapeutics (TNGX) - Stock Titan
TNGX Stock Crashes 20% After Reporting $0 Revenue In Q1 — But Analysts Still See Massive Upside - Stocktwits
Woodline Partners reports 8.0M-share stake in Tango Therapeutics (TNGX) - Stock Titan
RTW Funds disclose 13.3M shares in Tango Therapeutics (NASDAQ: TNGX) - Stock Titan
DeFi Technologies, Babcock & Wilcox And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Why Figma Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
TNGX: Financial Update and Future Outlook - GuruFocus
Tango Therapeutics (NASDAQ: TNGX) widens Q1 loss but holds $380M cash runway - Stock Titan
Cancer drug developer Tango has $380M cash, funding combo trials into 2028 - Stock Titan
Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
Adage (NASDAQ: TNGX) discloses 8.98% ownership of Tango Therapeutics - Stock Titan
Farallon (TNGX) reports 9.10M shares and 2.16M warrants in amendment - Stock Titan
Stifel Remains Bullish on Tango Therapeutics (TNGX)
RVMD Reports Wider-Than-Expected Loss in Q1, Raises '26 Expense View
Most and least shorted stocks over $2B market cap
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Most and least shorted mid-to mega-cap healthcare stocks in May
Tango Therapeutics (TNGX) director receives RSU and option grants as board compensation - Stock Titan
Tango Therapeutics (TNGX) price target increased by 32.09% to 20.06 - MSN
Tango Therapeutics (TNGX) price target increased by 11.68% to 24.38 - MSN
How New C-Suite Hires At Tango Therapeutics (TNGX) Have Changed Its Investment Story - simplywall.st
Tango Therapeutics Stock Suddenly Reverses After Huge Run - TipRanks
Analysts Set Tango Therapeutics, Inc. (NASDAQ:TNGX) Target Price at $20.67
Stifel raises Tango Therapeutics stock price target on drug combo potential - Investing.com
[Form 3] Tango Therapeutics, Inc. Initial Statement of Beneficial Ownership - Stock Titan
CFO Matthew Gall (TNGX) files Form 3 with no reported trades - Stock Titan
Does Erasca (ERAS) Expanding ERAS-0015 to China Recast Its Global Oncology Ambitions?
Massachusetts Financial Services Co. MA Acquires New Shares in Tango Therapeutics, Inc. $TNGX
Insider Selling: Tango Therapeutics (NASDAQ:TNGX) Insider Sells $961,500.00 in Stock
Is Tango Therapeutics (TNGX) Building the Right Leadership Mix to Navigate Complex Oncology Pipelines?
Most shorted mid cap stocks as of mid-April
Erasca (ERAS) Climbs 390% YTD on ‘Best-in-Class’ Potential of Cancer Treatment
Tango Therapeutics (TNGX) R&D president exercises options and sells stock - Stock Titan
Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat
Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat
Tango brings in 3 executives to speed a pancreatic cancer drug toward approval - Stock Titan
New CFO and senior leaders join Tango Therapeutics (NASDAQ: TNGX) - Stock Titan
Tango Therapeutics President Sells 27,000 Shares for $572,000 as Share Price Skyrockets
Tango Therapeutics President Sells 27,000 Shares for $572,000 as Share Price Skyrockets
Healthcare quant check: RLAY and TNGX lead Seeking Alpha’s top picks ahead of Q1 earnings
Most and least shorted stocks over $2B market cap
Stifel and Jefferies Raise Targets on Tango Therapeutics (TNGX) - Yahoo Finance
Adam Crystal Sells 27,000 Shares of Tango Therapeutics (NASDAQ:TNGX) Stock
Most and least shorted mid-to mega-cap healthcare stocks in March
Tango a new Buy at Canaccord Genuity on 2026 catalysts
Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Average Rating of “Moderate Buy” by Analysts
Tango Therapeutics is the best performing healthcare stock in March
Tango Therapeutics Insider Sells $304,000 in Stock Amid a 36% Single-Day Surge
Tango Therapeutics Insider Sells $304,000 in Stock Amid a 36% Single-Day Surge
Evaluating Tango Therapeutics (TNGX) Rich Valuation After Recent Share Price Momentum
Adam Crystal Sells 12,000 Shares of Tango Therapeutics (NASDAQ:TNGX) Stock
This Stock Is Up 1,229% in Just the Past Year, But Don’t Bet Your Retirement Money on It
Avoro Capital Advisors LLC Takes $4.58 Million Position in Tango Therapeutics, Inc. $TNGX
Tango Therapeutics’ (TNGX) Sees Cautious Analyst Optimism Following Earnings
Wedbush Reaffirms Outperform Rating for Tango Therapeutics (TNGX)
X4 Pharmaceuticals, Immuneering and Tango Therapeutics Are Getting New Analyst Attention
Is Erasca (ERAS) Quietly Reframing Its RAS Strategy With Tango’s Dual-Target Trial Collaboration?
Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing
Tango Therapeutics, Inc. (NASDAQ:TNGX) Receives $15.86 Average Target Price from Brokerages
Tango Therapeutics (TNGX) Valuation Check After Strong Share Price Momentum And High P/S Multiple
Tango Therapeutics (TNGX) Valuation Check After Strong Share Price Momentum And High P/S Multiple - Yahoo Finance
Tango Therapeutics (TNGX) Soars 52% on Buy Reco
Tango Therapeutics (NASDAQ:TNGX) Sets New 12-Month High Following Earnings Beat
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TNGX Stock Hits Record High on Inking Collaboration Deal With ERAS
TNGX Stock Hits Record High on Inking Collaboration Deal With ERAS
Investment Manager Loads Up on CELC Stock, Adds 135,000 Shares, According to Latest SEC Filing
TNGX Stock Hits Record High on Inking Collaboration Deal With ERAS - Yahoo Finance
Tango Therapeutics Stock Jumps 36% to a New High. Here’s What’s Driving the Move - TIKR.com
Tango rises after Q4 results, clinical pact with Erasca
12 Health Care Stocks Moving In Thursday's Intraday Session
Most and least shorted small-to-mid-cap stocks
Tango Therapeutics GAAP EPS of -$0.29 beats by $0.03, revenue of $0M misses by $0.5M
Tango Therapeutics Q4 Earnings Summary & Key Takeaways
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
Earnings Scheduled For March 5, 2026
Pancreatic cancer bet: Tango sets 2026 pivotal trial with $343M war chest - Stock Titan
Tango Therapeutics (TNGX) Hits All-Time High as Analyst Turns Bullish - Yahoo Finance
Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing
Examining the Future: Tango Therapeutics's Earnings Outlook
Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing - The Motley Fool
Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing - Yahoo Finance
Most and least shorted healthcare stocks with up to $2B market cap in February
Insider Selling: Tango Therapeutics (NASDAQ:TNGX) Insider Sells $693,985.65 in Stock
$TNGX stock is up 7% today. Here's what we see in our data. - Quiver Quantitative
Tango Therapeutics CEO Teases Pivotal Vopimetostat Trial, RAS Combo Data at Guggenheim Chat
Tango Therapeutics, Inc. (TNGX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
$TNGX stock is up 15% today. Here's what we see in our data. - Quiver Quantitative
Tango Therapeutics (NASDAQ:TNGX) Reaches New 52-Week High – Time to Buy?
Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor
Tango Therapeutics Appoints Sung Lee to Board of Directors